Patiromer and sodium zirconium cyclosilicate maintained potassium homeostasis in patients hyperkalemic patients on RAAS drugs. Hyperkalemia in patients with chronic kidney disease (CKD) remains a ...

Hyperkalemia is a potentially serious condition that can result in life-threatening cardiac arrhythmias and is associated with an increased mortality risk. Patients older than 65 years who have an ...

Understanding predictors of recurrent hyperkalemia may help health care providers provide a more individualized approach to hyperkalemia management. Hyperkalemia recurrence is more likely in patients ...

A recent population-based study assessed the incidence of clinically significant hyperkalemia among adult CKD patients being treated with RAASis and how this affected future treatment. In the study, 9 ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window As explained by ...

BOSTON, July 20, 2021 /PRNewswire/ -- Analysis Group, a global leader in health economics and outcomes research (HEOR), published a real-world study of inpatient management of hyperkalemia and ...

Please provide your email address to receive an email when new articles are posted on . During study follow-up, 93 patients developed kidney failure with replacement therapy and 134 patients died.

ST. GALLEN, Switzerland, Sept. 24, 2024 /PRNewswire/ -- CSL Vifor today announced that Japan's Ministry of Health and Labor Welfare (MHLW) has granted its partner, Zeria Pharmaceutical Co., Ltd.

Please provide your email address to receive an email when new articles are posted on . In addition to being male and of older age, being Black or Hispanic can increase a patient’s risk for ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. AstraZeneca has launched the Hyperkalemia ...

AstraZeneca has recently completed a Phase IV clinical study titled ‘Phase IV, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Trial Evaluating Sodium Zirconium Cyclosilicate (SZC) for the ...

If you have hyperkalemia -- high levels of potassium -- your treatment will depend on how high your levels have risen, how quickly it happened, and whether you have serious symptoms. Severe ...